CH615925A5 - - Google Patents

Download PDF

Info

Publication number
CH615925A5
CH615925A5 CH1210375A CH1210375A CH615925A5 CH 615925 A5 CH615925 A5 CH 615925A5 CH 1210375 A CH1210375 A CH 1210375A CH 1210375 A CH1210375 A CH 1210375A CH 615925 A5 CH615925 A5 CH 615925A5
Authority
CH
Switzerland
Prior art keywords
endo
hydrogen
compound
preparation
bicyclo
Prior art date
Application number
CH1210375A
Other languages
German (de)
English (en)
Inventor
Ronald Leslie Buchanan
Alex Michael Jelenevsky
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH615925A5 publication Critical patent/CH615925A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH1210375A 1974-09-18 1975-09-18 CH615925A5 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50702974A 1974-09-18 1974-09-18
US05/594,918 US3980668A (en) 1974-09-18 1975-07-10 Anti-arrhythimic 5-endo-(3-indolecarbonyloxy)-N-[amino-(lower)alkyl]bicyclo[2,2,1]heptane-2,3-di-endo-carboxylic acid imides

Publications (1)

Publication Number Publication Date
CH615925A5 true CH615925A5 (pl) 1980-02-29

Family

ID=27055675

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1210375A CH615925A5 (pl) 1974-09-18 1975-09-18

Country Status (24)

Country Link
US (1) US3980668A (pl)
JP (1) JPS6039669B2 (pl)
AR (1) AR212235A1 (pl)
AT (1) AT345275B (pl)
CA (1) CA1068281A (pl)
CH (1) CH615925A5 (pl)
CS (1) CS187489B2 (pl)
DD (1) DD123092A5 (pl)
DE (1) DE2541434A1 (pl)
DK (1) DK418075A (pl)
ES (2) ES441038A1 (pl)
FI (1) FI64352C (pl)
FR (1) FR2313047A1 (pl)
GB (1) GB1484214A (pl)
HU (1) HU173807B (pl)
IE (1) IE42051B1 (pl)
IL (1) IL48096A (pl)
LU (1) LU73418A1 (pl)
NL (1) NL7510934A (pl)
NO (1) NO144072C (pl)
PH (1) PH11498A (pl)
PL (2) PL100522B1 (pl)
SE (1) SE421421B (pl)
YU (2) YU40123B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557341A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung
US4139533A (en) * 1976-08-19 1979-02-13 Bristol-Myers Company Bicyclo[2,2,1]heptane-2,3-diendo carboxylic acid imide esters of quinoline carboxylic acid
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3850921A (en) * 1972-09-20 1974-11-26 I Matuo Derivatives of 2,3-norbornanedicarboxamide

Also Published As

Publication number Publication date
NO144072B (no) 1981-03-09
HU173807B (pl) 1979-08-28
NO144072C (no) 1981-06-17
IL48096A (en) 1979-09-30
YU225375A (en) 1983-12-31
FI752572A (pl) 1976-03-19
FR2313047B1 (pl) 1979-09-14
PH11498A (en) 1978-02-01
FI64352B (fi) 1983-07-29
JPS51131871A (en) 1976-11-16
US3980668A (en) 1976-09-14
PL101454B1 (pl) 1978-12-30
CS187489B2 (en) 1979-01-31
SE421421B (sv) 1981-12-21
DE2541434A1 (de) 1976-04-08
DD123092A5 (pl) 1976-11-20
ATA718575A (de) 1978-01-15
AU8459775A (en) 1977-03-10
YU40123B (en) 1985-08-31
AR212235A1 (es) 1978-06-15
ES441038A1 (es) 1977-07-01
DK418075A (da) 1976-03-19
IE42051L (en) 1976-03-18
NL7510934A (nl) 1976-03-22
PL100522B1 (pl) 1978-10-31
FI64352C (fi) 1983-11-10
FR2313047A1 (fr) 1976-12-31
AT345275B (de) 1978-09-11
ES455938A1 (es) 1978-02-01
GB1484214A (en) 1977-09-01
YU284082A (en) 1985-04-30
IL48096A0 (en) 1975-11-25
CA1068281A (en) 1979-12-18
JPS6039669B2 (ja) 1985-09-06
IE42051B1 (en) 1980-05-21
LU73418A1 (pl) 1976-08-13
NO753128L (pl) 1976-03-19
SE7510362L (sv) 1976-03-19

Similar Documents

Publication Publication Date Title
DE2305092C2 (pl)
EP0171728A1 (de) Neue Tryptamin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung
DD153372A5 (de) Verfahren zur herstellung von neuen ergolinderivaten
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE2347142C2 (de) 5-endo-Benzoyloxy-N-(3-dimethylamino-propyl)-bicyclo-[2.2.1]heptan-2,3-di-endo-carbonsäureimid, deren Säureadditionssalze Verfahren zu deren Herstellung und pharmazeutisches Mittel
DD143254A5 (de) Verfahren zur herstellung von tetrahydroisochinolin-derivaten
EP0086416A2 (de) Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2632118C3 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
EP0155903A1 (de) Indolophenanthridine, ihre Herstellung und Verwendung
CH615925A5 (pl)
DE2026080C3 (de) 5-Methyl-10-( ß -alkylaminoäthyl)- dibenzothiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Zusammensetzungen
CH649999A5 (de) 10-brom-e-homo-eburnane.
DE3512629C2 (de) s-Triazolo[1,5-a]pyrimidine und Verfahren zu ihrer Herstellung
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
DE2924880A1 (de) 2-aminooctahydroindolo eckige klammer auf 2,3-a eckige klammer zu chinolizin-verbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
DE1076691B (de) Verfahren zur Herstellung von Phenthiazinderivaten
EP0777663B1 (de) Verwendung von substituierten 6-amino-4h-pyranen
CH623039A5 (pl)
DE3324727C2 (pl)
EP0924211A2 (de) 1,2-überbrückte 1,4-Dihydropyridinen als selektive Kaliumkanalmodulatoren
CH645106A5 (de) Substituierte chinazoline sowie mittel zur behandlung von hypertonie und bradykardie.
DE2733056C2 (de) Vincamenin und seine Säureadditionssalze, solche enthaltende Arzneimittel sowie Verfahren zur Herstellung der genannten Verbindungen
DE2013256C (pl)
DE2710807C2 (de) Benzylamino-alkancarboxamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased